Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated ELGN2-Mediated Oxygen-Sensing Response

Chromosomal abnormalities, such as structural and numerical abnormalities, are a common occurrence in cancer. The close association of homologous chromosomes during interphase, a phenomenon termed somatic chromosome pairing, has been observed in cancerous cells, but the functional consequences of somatic pairing have not been established. Gene expression profiling studies revealed that somatic pairing of chromosome 19 is a recurrent chromosomal abnormality in renal oncocytoma, a neoplasia of the adult kidney. Somatic pairing was associated with significant disruption of gene expression within the paired regions and resulted in the deregulation of the prolyl-hydroxylase ELGN2, a key protein that regulates the oxygen-dependent degradation of hypoxia-inducible factor (HIF). Overexpression of ELGN2 in renal oncocytoma increased ubiquitin-mediated destruction of HIF and concomitantly suppressed the expression of several HIF-target genes, including the pro-death BNIP3L gene. The transcriptional changes that are associated with somatic pairing of chromosome 19 mimic the transcriptional changes that occur following DNA amplification. Therefore, in addition to numerical and structural chromosomal abnormalities, alterations in chromosomal spatial dynamics should be considered as genomic events that are associated with tumorigenesis. The identification of EGLN2 as a significantly deregulated gene that maps within the paired chromosome region directly implicates defects in the oxygen-sensing network to the biology of renal oncocytoma.

[1]  K. Takeda,et al.  Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins. , 2008, Blood.

[2]  R. Hill,et al.  Hypoxia and Metastasis , 2007, Clinical Cancer Research.

[3]  R. Hill,et al.  Hypoxia-regulated p53 and its effect on radiosensitivity in cancer cells , 2007, International journal of radiation biology.

[4]  M. McMullin,et al.  A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Myers,et al.  Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data , 2005, Nucleic acids research.

[6]  W. Kaelin,et al.  Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. , 2005, Cancer cell.

[7]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[8]  Bin Tean Teh,et al.  A molecular classification of papillary renal cell carcinoma. , 2005, Cancer research.

[9]  K. Dykema,et al.  Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma , 2005, BMC Genomics.

[10]  Yuen-Li Chung,et al.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.

[11]  I. V. Soloviev,et al.  An Approach for Quantitative Assessment of Fluorescence In Situ Hybridization (FISH) Signals for Applied Human Molecular Cytogenetics , 2005, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[12]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[13]  Eyal Gottlieb,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[14]  M. Fiscella,et al.  Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Burns,et al.  Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. , 2004, Cancer cell.

[16]  Jean YH Yang,et al.  Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.

[17]  D. Bowtell,et al.  Siah2 Regulates Stability of Prolyl-Hydroxylases, Controls HIF1α Abundance, and Modulates Physiological Responses to Hypoxia , 2004, Cell.

[18]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[19]  M. Ohh,et al.  von Hippel-Lindau Tumor Suppressor Protein and Hypoxia-Inducible Factor in Kidney Cancer , 2004, American Journal of Nephrology.

[20]  H. Tanke,et al.  Somatic pairing of centromeres and short arms of chromosome 15 in the hematopoietic and lymphoid system , 1993, Human Genetics.

[21]  A. Raap,et al.  Somatic pairing of chromosome 1 centromeres in interphase nuclei of human cerebellum , 1989, Human Genetics.

[22]  M. Schmid,et al.  Centromeric association and non-random distribution of centromeres in human tumour cells , 2004, Human Genetics.

[23]  Rafael A Irizarry,et al.  Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.

[24]  K. Arden,et al.  Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. , 2002, Cancer research.

[25]  K. Furge,et al.  Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data , 2002, Genome Biology.

[26]  Mircea Ivan,et al.  Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Christian A. Rees,et al.  Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Paetau,et al.  Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer , 2002, Nature Genetics.

[29]  G. Semenza,et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O 2 tension , 2002 .

[30]  G. Fu,et al.  Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  P. O’Farrell.  Faculty Opinions recommendation of Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. , 2001 .

[32]  W. Linehan,et al.  The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. , 2001, Cancer research.

[33]  S. McKnight,et al.  A Conserved Family of Prolyl-4-Hydroxylases That Modify HIF , 2001, Science.

[34]  A. Harris,et al.  HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. , 2001, Cancer research.

[35]  M S Pepe,et al.  Comparing disease screening tests when true disease status is ascertained only for screen positives. , 2001, Biostatistics.

[36]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[37]  M. Caligiuri,et al.  Expression profiling reveals fundamental biological differences in acute myeloid leukemia with isolated trisomy 8 and normal cytogenetics. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Alimonti,et al.  BNIP3 and Genetic Control of Necrosis-Like Cell Death through the Mitochondrial Permeability Transition Pore , 2000, Molecular and Cellular Biology.

[39]  M. Ivan,et al.  Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein , 2000, Nature Cell Biology.

[40]  Hongyue Dai,et al.  Widespread aneuploidy revealed by DNA microarray expression profiling , 2000, Nature Genetics.

[41]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[42]  D. Louis,et al.  The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. , 1998, Molecular cell.

[43]  M. Slovak,et al.  Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  M. Slovak,et al.  Aneusomy detection by fluorescence in situ hybridization (FISH) using bladder washings: correlation with cytology, cytogenetics and clinical features predicts recurrence and defines test limitations , 1997 .

[45]  G. Semenza,et al.  Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. , 1996, The American journal of physiology.

[46]  Ross Ihaka,et al.  Gentleman R: R: A language for data analysis and graphics , 1996 .

[47]  N. B. Atkin,et al.  Evidence for somatic pairing of chromosome 7 and 10 homologs in a follicular lymphoma. , 1996, Cancer genetics and cytogenetics.

[48]  P. Bugert,et al.  MUTATION OF THE VHL GENE IS ASSOCIATED EXCLUSIVELY WITH THE DEVELOPMENT OF NON‐PAPILLARY RENAL CELL CARCINOMAS , 1996, The Journal of pathology.

[49]  A. Brothman,et al.  Homologous centromere association of chromosomes 9 and 17 in prostate cancer. , 1995, Cancer genetics and cytogenetics.

[50]  L. Schmidt,et al.  Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. , 1995, Cancer research.

[51]  A. Kibel,et al.  Tumour suppression by the human von Hippel-Lindau gene product , 1995, Nature Medicine.

[52]  G. Semenza,et al.  Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[53]  R. Jenkins,et al.  Chromosomal aneusomies detected by fluorescent in situ hybridization analysis in clinically localized prostate carcinoma. , 1994, The Journal of urology.

[54]  J. Gnarra,et al.  Identification of the von Hippel-Lindau disease tumor suppressor gene. , 1993, Science.

[55]  G. KOVACS,et al.  Molecular differential pathology of renal cell tumours , 1993, Histopathology.

[56]  John C. Russ,et al.  The Image Processing Handbook , 2015 .

[57]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[58]  L. Sobin,et al.  The international histological classification of tumours. , 1981, Bulletin of the World Health Organization.

[59]  T. W. Ridler,et al.  Picture thresholding using an iterative selection method. , 1978 .